When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. List of 76 Psoriatic Arthritis Medications Compared - Drugs.com

    www.drugs.com/condition/psoriatic-arthritis.html

    Compare risks and benefits of common medications used for Psoriatic Arthritis. Find the most popular drugs, view ratings and user reviews.

  3. List of 76 Psoriatic Arthritis Medications Compared (Page 2) -...

    www.drugs.com/condition/psoriatic-arthritis.html?page_number=2

    Compare risks and benefits of common medications used for Psoriatic Arthritis. Find the most popular drugs, view ratings and user reviews. (Page 2)

  4. Apremilast, under the brand name Otezla, received FDA approval on March 21, 2014, for psoriatic arthritis. Since then, it has also been FDA-approved to treat types of plaque psoriasis and Behcet’s disease in specific patients. It is not available as a generic medicine.

  5. Humira is used to treat many inflammatory conditions in adults, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. Humira is also used in adults and children to treat Crohn's disease, juvenile idiopathic arthritis, ulcerative colitis and uveitis ...

  6. FDA Approved: Yes (First approved October 31, 2023) Brand name: Wezlana. Generic name: ustekinumab-auub. Dosage form: Injection. Company: Amgen Inc. Treatment for: Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, Ulcerative Colitis.

  7. Risankizumab brand name is Skyrizi. Risankizumab-rzaa is a monoclonal antibody that belongs to a class of medications called interleukin-23 antagonists. Skyrizi is given as a subcutaneous injection for plaque psoriasis and psoriatic arthritis.

  8. Guselkumab is a prescription medicine used to treat adults: with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light) with active psoriatic arthritis (PsA).

  9. Ustekinumab is a biologic drug that was originally approved to treat moderate to severe plaque psoriasis. Ustekinumab is now also approved to be used for psoriatic arthritis, Crohn’s disease and ulcerative colitis.

  10. Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Includes side effects, dose, interactions and indications.

  11. Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Includes Otezla side effects, dose, interactions and indications.